ADAPT: A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates

Sponsor
University of Dundee (Other)
Overall Status
Completed
CT.gov ID
NCT03293576
Collaborator
NHS Tayside (Other)
52
1
2
22.3
2.3

Study Details

Study Description

Brief Summary

The study evaluates the use of implementation intentions to increase self-efficacy and reduce injecting risk behaviour in a sample of injecting drug users on treatment for hepatitis C (HCV). The overall aim is to reduce HCV reinfection rates. The primary objective is to identify lower injecting risk behaviour scores in patients on treatment for hepatitis C receiving the psychosocial intervention compared to the same patient group assigned to the control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Volitional Help Sheet
N/A

Detailed Description

The intervention will entail completing a volitional help sheet.This will create implementation intentions, which are self-regulatory strategies taking the form of "if-then" plans (i.e. situation-solution plan).

Injecting risk behaviour scores and self-efficacy scores will be analysed for differences between intervention and control groups.

To control for contact-time with the researchers, participants in the control group will spend approximately 20 minutes with the researcher exploring Zimbardo's time perspective constructs (ZTPI, Zimbardo & Boyd, 1999) and completing the short Zimbardo's time perspective inventory (Orosz et al. 2017). The inventory was selected because the cognitive processes involved in accessing time constructs will also be activated in the intervention group for the planning of coping strategies and goal achievement during future injecting risk situations.

The study also aims:
  • To assess the variability in injecting risk behaviour as explained by subjective norms, social connectedness and group identification constructs;

  • To assess the variability in intervention effectiveness as explained by changes in mental health, illness perception subjective norms, social connectedness, and group identification.

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Prevention
Official Title:
Integrating Health Psychology Into Hepatitis c Treatment: a Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates
Actual Study Start Date :
Feb 22, 2018
Actual Primary Completion Date :
Jan 3, 2020
Actual Study Completion Date :
Jan 3, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

Volitional help sheet

Behavioral: Volitional Help Sheet
This brief intervention will last around 20 minutes. The participants and the researcher will read through the list of real-life solutions the participants might find applicable to them. They will then read through the list of situations one by one. The participant will draw a coloured line between the situation and the solution which seems more appropriate to them. The volitional help sheet helps create implementation intentions, which are self-regulatory strategies taking the form of "if-then" plans (i.e. situation-solution plan).

No Intervention: Control

Short Zimbardo's time perspective inventory (Orosz et al. 2017)

Outcome Measures

Primary Outcome Measures

  1. Injecting Risk Behaviour [4 weeks]

    Self-reported injecting risk behaviour over the past 4 weeks. Seventeen items scored 1-4 (1 frequently, 4 never)

  2. Self-Efficacy [4 weeks]

    Self-reported confidence in one's own ability to refuse sharing of injecting equipment and use of old injecting equipment. Fifteen items scored 1-7 (1 high confidence, 7 low confidence)

Secondary Outcome Measures

  1. Subjective Norms [Up to 4 weeks]

    Self-reported social norms of individual's injecting network. Four items scored 1-7 (1 strong acceptance of sharing equipment, 7 no acceptance of sharing equipment).

  2. Social Connectedness [Up to 8 weeks]

    Self-reported perceived social connectedness to general society. Eight items scored 1-6 (1 low connectedness, 6 high connectedness)

  3. Group Identification [Up to 8 weeks]

    Self-reported perceived identification with family group and injecting group. Eight items scored 1-7 (1 high identification, 7 low identification).

  4. Depression [2 weeks]

    Self-reported depressive symptoms over the past 2 weeks. Nine items scored 0-3 (0 no symptoms, 3 depressive symptoms)

  5. Anxiety [2 weeks]

    Self-reported depressive symptoms over the past 2 weeks. Nine items scored 0-3 (0 no symptoms, 3 depressive symptoms)

  6. Post traumatic stress disorder [1 month]

    Self-reported trauma-induced stress symptoms over the past month. Five items scored Yes/No.

  7. Working alliance [Treatment duration (12 weeks)]

    Self-reported therapeutic alliance with provider of hepatitis C treatment care over treatment duration. Eight items scored 1-5 (1 poor alliance, 5 excellent alliance).

  8. Illness perception [Up to 8 weeks]

    Self-reported perception of hepatitis C as an illness. Eight items scored 1-10 (1 no impact on quality of life, 10 high impact on quality of life).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or Female. (Over 18 years of age);

  • Chronic HCV positive infection;

  • Current illicit drug use established through participants' self-report;

  • Current HCV treatment provided by the NHS;

  • Informed consent, agreeing to study and monitoring criteria;

  • English-speaking.

Exclusion Criteria:
  • Inability to provide informed consent;

  • Aggressive or violent behaviour;

  • Not currently receiving HCV treatment;

  • Inability to communicate in English.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cairn Centre Needle Exchange Dundee United Kingdom DD1 4NA

Sponsors and Collaborators

  • University of Dundee
  • NHS Tayside

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
John Dillon, Professor, University of Dundee
ClinicalTrials.gov Identifier:
NCT03293576
Other Study ID Numbers:
  • 2017PZ04
First Posted:
Sep 26, 2017
Last Update Posted:
Aug 14, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by John Dillon, Professor, University of Dundee
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 14, 2020